This technology is a deep-learning-based model that synthesizes positron emission tomography (PET) maps of pathological burden from MRI to detect Alzheimer’s disease.
Positron emission tomography (PET) is considered the gold standard molecular measure of Alzheimer’s pathology. However, this method is expensive, not universally available, and exposes patients to ionizing radiation. In contrast, T1-weighted (T1w) MRI is widely available, cost-effective, and does not expose patients to ionizing radiation. However, T1w MRI is unable to generate standardized uptake value ratio (SUVR) maps of pathological burden, which is necessary for determining the molecular pathology of Alzheimer’s disease.
This technology is a deep-learning-based framework that generates synthetic PET maps from T1w MRI for the detection of Alzheimer’s disease. Structural, morphometric, and vascular features are integrated from MRI to synthesize PET SUVR maps. This hybrid deep learning architecture achieves high concordance with ground-truth PET imaging and improves performance when vascular and morphometric priors are included.
IR CU26244
Licensing Contact: Jerry Kokoshka